Jennifer Reichel, MD
MOHS-Micrographic Surgery · Seattle, WANPI 1043259856
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,292 of the $5,292 with a category attached, or 62.2%. 22 manufacturers reported payments, led by Lumenis BE LTD at 37.8% of the total.
Across 111 payments — averaging $47.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE LTD$2K
- Merz North America, Inc.$1K
- AbbVie$749
- Galderma Laboratories, L.p.$486
- Lilly USA, LLC$148
- Novartis$137
- plus $519 from 16 others
What the payments were for
- Speaking & faculty fees$2,00038%
- Food & beverage$3,29262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE LTD | 1 | $2,000 |
| Merz North America, Inc. | 12 | $1,254 |
| AbbVie(2 entities) | 34 | $749 |
| Galderma Laboratories, L.p. | 27 | $486 |
| Lilly USA, LLC | 7 | $148 |
| Novartis | 7 | $137 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| LEO Pharma Inc. | 3 | $68 |
| Amgen | 2 | $47 |
| Johnson & Johnson | 2 | $42 |
| Pfizer | 2 | $40 |
| Incyte Corporation | 1 | $29 |
| Boehringer Ingelheim | 1 | $28 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $25 |
| Sanofi | 1 | $24 |
| Organogenesis Inc. | 1 | $23 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Bristol Myers Squibb | 1 | $23 |
| Revance Therapeutics, Inc. | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$312
How this compares
$5,292 in reported general payments places this provider in the 85th percentile of 38 mohs-micrographic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acitretin | 18 | $3,135 |
| Cephalexin | 56 | $371 |
| Ciprofloxacin Hcl | 30 | $222 |
| Mupirocin | 14 | $98 |
| Oxycodone Hcl | 15 | $18 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Seattle
- David WangSeattle$1K
- Cheryl GustafsonSeattle$1K
- Ravi KrishnanSeattle$526
- Kelly Griffith-BauerSeattle$359
- Daniel BergSeattle$125
- Annalisa GormanSeattle$65
- Darrell FaderSeattle$59
- Scott IsenhathSeattle$30
- Wesley WuSeattle$30
- Craig BirkbySeattle$28
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.